Moberg Pharma AB (publ) (STO:MOB)

Market Cap	383.76M
Revenue (ttm)	12.35M
Net Income (ttm)	-254.73M
Shares Out	47.00M
EPS (ttm)	-5.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,569
Average Volume	64,822
Open	8.22
Previous Close	8.23
Day's Range	8.17 - 8.43
52-Week Range	6.34 - 19.66
Beta	0.73
RSI	42.08
Earnings Date	Nov 11, 2025

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 10
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MOB